MAP1LC3B and adult-onset Still disease: As shown in Figure 3, significantly higher mRNA expression levels of Atg5 and LC3-II (MAP1LC3B) were observed in AOSD patients (median 8.53, IQR 1.35-36.60; 5.86, 0.30-23.08; respectively) than in HCs (0.71, 0.481.21, p < 0.001; 0.31, 0.22-0.58, p < 0.01; respectively).